Dec. 23 at 6:58 PM
$TSOI Ruh Roh! 😖
Patel, Ricordi, Lanzoni, Kenyon, Bin Yan, et al…..
“Interesting to note, under the CTE/TBI licensing arrangement, Dr. Patel and Jadi Cell LLC had 115 million shares of TSOI. News like being involved in a Phase 1/2 and then Phase 3 study could realistically help improve the price per share of stock held in TSOI (in fact, it did ...).
As of today, neither Jadi Cell LLC nor UM has produced any agreement between the parties other than the MTA of 2018 which Mr. Black, legal counsel for Jadi Cell LLC said did not cover any clinical trials.”
Securities manipulation? 🤨
ZERO agreement(s) to perform UofM P1/2a clinical trial?!?
Oooof!! 👀
Oh well, upward and onward! 👍🚂
https://www.sec.gov/Archives/edgar/data/1419051/000149315223004263/ex99-1.htm